Algernon Pharmaceuticals Inc. (AGN.CN)
CAD 0.08
(-5.88%)
CAD 0.08
(-5.88%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | -50.39 Thousand CAD | -44.26% |
| 2022 | -34.93 Thousand CAD | 0.0% |
| 2021 | - CAD | 0.0% |
| 2020 | - CAD | 100.0% |
| 2019 | -26.99 Thousand CAD | 34.08% |
| 2018 | -40.95 Thousand CAD | 67.89% |
| 2017 | -127.53 Thousand CAD | -165.92% |
| 2016 | -47.96 Thousand CAD | 0.0% |
| 2015 | - CAD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | -7642.00 CAD | -2.88% |
| 2024 Q1 | -7428.00 CAD | 44.31% |
| 2024 Q3 | -6085.00 CAD | 20.37% |
| 2023 Q4 | -13.33 Thousand CAD | -3.95% |
| 2023 Q2 | -12.53 Thousand CAD | -7.23% |
| 2023 FY | -50.39 Thousand CAD | -44.26% |
| 2023 Q1 | -11.69 Thousand CAD | 58.81% |
| 2023 Q3 | -12.83 Thousand CAD | -2.36% |
| 2022 Q3 | -1966.00 CAD | 57.15% |
| 2022 Q4 | -28.38 Thousand CAD | -1343.64% |
| 2022 FY | -34.93 Thousand CAD | 0.0% |
| 2022 Q2 | -4588.00 CAD | 0.0% |
| 2022 Q1 | - CAD | 0.0% |
| 2021 Q4 | - CAD | 0.0% |
| 2021 Q1 | - CAD | 0.0% |
| 2021 Q2 | - CAD | 0.0% |
| 2021 Q3 | - CAD | 0.0% |
| 2021 FY | - CAD | 0.0% |
| 2020 Q2 | - CAD | 0.0% |
| 2020 Q4 | - CAD | 0.0% |
| 2020 Q3 | - CAD | 0.0% |
| 2020 Q1 | - CAD | 0.0% |
| 2020 FY | - CAD | 100.0% |
| 2019 FY | -26.99 Thousand CAD | 34.08% |
| 2019 Q4 | - CAD | 0.0% |
| 2019 Q3 | - CAD | 0.0% |
| 2019 Q2 | - CAD | 0.0% |
| 2019 Q1 | - CAD | 0.0% |
| 2018 Q1 | - CAD | 0.0% |
| 2018 FY | -40.95 Thousand CAD | 67.89% |
| 2018 Q4 | - CAD | 0.0% |
| 2018 Q3 | - CAD | 0.0% |
| 2018 Q2 | - CAD | 0.0% |
| 2017 Q1 | - CAD | 0.0% |
| 2017 Q2 | - CAD | 0.0% |
| 2017 Q3 | - CAD | 0.0% |
| 2017 Q4 | - CAD | 0.0% |
| 2017 FY | -127.53 Thousand CAD | -165.92% |
| 2016 FY | -47.96 Thousand CAD | 0.0% |
| 2016 Q4 | - CAD | 0.0% |
| 2016 Q3 | - CAD | 0.0% |
| 2016 Q2 | - CAD | 0.0% |
| 2016 Q1 | - CAD | 0.0% |
| 2015 FY | - CAD | 0.0% |
| 2015 Q4 | - CAD | 0.0% |
| 2015 Q3 | - CAD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Asep Medical Holdings Inc | -113.74 Thousand CAD | 55.69% |
| BetterLife Pharma Inc. | - CAD | Infinity% |
| BioVaxys Technology Corp. | - CAD | Infinity% |
| ChitogenX Inc. | -42 Thousand CAD | -19.995% |
| Rapid Dose Therapeutics Corp. | 563.4 Thousand CAD | 108.945% |
| Defence Therapeutics Inc. | -90.92 Thousand CAD | 44.571% |
| Entheon Biomedical Corp. | 250.32 Thousand CAD | 120.133% |
| Gemina Laboratories Ltd. | -93.36 Thousand CAD | 46.022% |
| Glow Lifetech Corp. | -505.62 Thousand CAD | 90.033% |
| Lexston Life Sciences Corp. | -26.39 Thousand CAD | -90.945% |
| Pharmala Biotech Holdings Inc. | 454.09 Thousand CAD | 111.098% |
| Doseology Sciences Inc. | -36.08 Thousand CAD | -39.669% |
| MYND Life Sciences Inc. | -332.99 Thousand CAD | 84.865% |
| Nova Mentis Life Science Corp. | 25.4 Thousand CAD | 298.378% |
| PharmaTher Holdings Ltd. | -711.00 CAD | -6988.326% |
| PreveCeutical Medical Inc. | -9856.00 CAD | -411.343% |
| Telescope Innovations Corp. | 595.39 Thousand CAD | 108.465% |